- Release Date: 01/06/20 08:49
- Summary: ASCO 2020 Highlights NOX66 Potential in Late-Stage Cancer
- Price Sensitive: Yes
- Download Document 158.71KB
- Forums
- ASX - By Stock
- Ann: ASCO 2020 Highlights NOX66 Potential in Late-Stage Cancer
Ann: ASCO 2020 Highlights NOX66 Potential in Late-Stage Cancer
-
- There are more pages in this discussion • 12 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add NOX (ASX) to my watchlist
(20min delay)
|
|||||
Last
10.8¢ |
Change
-0.013(10.4%) |
Mkt cap ! $33.60M |
Open | High | Low | Value | Volume |
11.0¢ | 11.5¢ | 10.8¢ | $21.50K | 195.5K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
7 | 120885 | 10.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
11.5¢ | 39408 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
7 | 120885 | 0.105 |
5 | 143641 | 0.100 |
1 | 53000 | 0.096 |
1 | 20000 | 0.095 |
1 | 11000 | 0.088 |
Price($) | Vol. | No. |
---|---|---|
0.115 | 39408 | 1 |
0.120 | 48477 | 2 |
0.125 | 66800 | 1 |
0.130 | 162463 | 5 |
0.135 | 30000 | 1 |
Last trade - 14.25pm 13/11/2024 (20 minute delay) ? |
Featured News
NOX (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
SPONSORED BY The Market Online